NYSE Suspends Accendra Health Trading and Begins Delisting Proceedings
The NYSE suspended trading in Accendra Health common stock effective November 16, 2026, and began delisting proceedings over abnormally low selling prices. The stock began trading on OTCQB as ACCH on November 17.
The NYSE suspended trading of Accendra Health common stock effective November 16, 2026, and began delisting proceedings over abnormally low selling prices. The stock began trading on OTCQB as ACCH on November 17.Material DetailsContext by AI AnalystThis is a significant listing-status event amid th…